Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression

Journal of Pathology

Volumn 198, Issue 4, 2002, Pages 428-434

  Elder, Douglas J E ^a   Baker, Jenny A ^a   Banu, Nahida A ^a   Moorghen, Moganaden ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ISOPROTEIN;

ADENOCARCINOMA; ADENOMA; ARTICLE; CELL GROWTH; CELL SURVIVAL; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0036899474     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1232     Document Type: Article

References (33)

1. Gupta RA, DuBois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev (Cancer) 2001; 1: 11-21.
2. Sheehan KM, Sheahan K, O'Donoghue DP, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. J Am Med Assoc 1999; 282: 1254-1257.
3. Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999; 128: 1121-1132.
4. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
5. Kargman SL, O'Neill GP, Vickers PJ, et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 2556-2559.
6. Sano H, Kawabito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789.
7. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809.
8. Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, et al. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcin 1999; 24: 177-187.
9. Bamba H, Ota S, Kato A, et al. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 1999; 83: 470-475.
10. Hao X, Bishop AE, Wallace M, et al. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 1999; 187: 295-301.
11. Chapple KS, Cartwright EJ, Hawcroft G, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000; 156: 545-553.
12. Elder DJE, Hague A, Halton DE, et al. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 selective non-steroidal anti -inflammatory drug: independence from cyclooxygenase-2 protein expression. Clin Cancer Res 1997: 3: 1679-1683.
13. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 97: 2254-2259.
14. Sinicrope FA, Lemoine M, Xi L, et al. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancer. Gastroenterology 1999; 117: 350-358.
15. Chen W-S, Wei S-J, Liu MJ, et al. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, Etodolac. Int J Cancer 2001; 91: 894-899.
16. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. PNAS 1997; 94: 3336-3340.
17. Yang VW, Shields JM, Hamilton SR, et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 1998; 58: 1750-1753.
18. Howe LR, Subbaramaiah K, Chung WJ, et al. Transcriptional activation of cyclooxygenase-2 in Wnt- 1 -transformed mouse mammary epithelial cells. Cancer Res 1999; 59: 1572-1577.
19. Hsi LC, Angerman-Stewart J, Eling TE. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 1999; 20: 2045-2049.
20. Mei JM, Hord NG, Winterstein DF, et al. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated b-catenin-LEF-1 transcriptional complex in mouse colonic epithelial cells contrasting in Apc. Carcinogenesis 1999; 20:737-740.
21. Lamlum H, Papadopoulou A, Ilyas M, et al. APC mutations are sufficient for the growth of early colorectal adenomas. PNAS 2000; 97: 2225-2228.
22. Sheng H, Williams CS, Shao J, et al. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 1998; 273: 22120-22127.
23. Schmedtje JF, Ji Y-S, Liu W-L, et al. Hypoxia induces cyclooxygenase-2 via the NF-kB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601-608.
24. Lasa M, Mahtni KR, Finch A, et al. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000; 20: 4265-4274.
25. Vogel C, Boerboom A-MJF, Baechle C, et al. Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway. Carcinogenesis 2000; 21: 2267-2274.
26. Xie W, Fletcher BS, Anderson RD, et al. v-src induction of the TIS10/PGS2 prostaglandin synthase gene mediated by an ATF/CRE transcription response element. Mol Cell Biol 1994; 14: 6531-6539.
27. Kim Y, Fischer SM. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. J Biol Chem 1998; 273: 27686-27694.
28. Ramsay RG, Friend A, Vizantios Y, et al. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti -inflammatory drug target, is regulated by c-MYB. Cancer Res 2000; 60: 1805-1809.
29. Khan KNM, Masferrer JL, Woerner BM, et al. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand J Gastroenterol 2001; 36: 865-869.
30. Tjandrawinata RR, Dahiya R, Hughes-Fulford M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer 1997; 75: 1111-1118.
31. Meade EA, McIntyre TM, Zimmerman GA, et al. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999; 274: 8328-8334.
32. Qiao L, Kozoni V, Tsioulias GJ, et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta 1995; 1258: 215-223.
33. Williams CS, Tsujii M, Reese J, et al. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000; 105: 1589-1594.